Piramal Pharma reports consolidated net loss of Rs 81.70 crore in Q1

29 Jul 2025 Evaluate

Piramal Pharma has reported result for first quarter ended June 30, 2025 (Q1FY26). 

The company has reported 32.68% rise in its net profit at Rs 113.14 crore for the quarter ended June 30, 2025 as compared to Rs 85.27 crore for the same quarter in the previous year. The total income of the company increased by 4.62% at Rs 1150.80 crore for Q1FY26 as compared to Rs 1099.96 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported net loss of Rs 81.70 crore for Q1FY26 as compared to net loss of Rs 88.64 crore for the same quarter in the previous year. However, the total income of the company increased by 1.09% at Rs 1992.11 crore for Q1FY26 as compared to Rs 1970.68 crore for the corresponding quarter previous year.

Piramal Pharma Share Price

179.95 -0.60 (-0.33%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×